Search research articles
Contact Us
Filters
Showing results (101-110 of 740) with videos related to
Page
of 74
Sort By:
Blood
|
April 4, 2015
Treatment options for relapsed and refractory multiple myeloma
Ajay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.
Blood Cancer Journal
|
January 14, 2018
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia
|
November 19, 2022
Managing Waldenström's macroglobulinemia with BTK inhibitors
Christian Buske, Wojciech Jurczak, Joe-Elie Salem, et al.
Therapeutic Advances in Hematology
|
February 22, 2021
Current and novel BTK inhibitors in Waldenström's macroglobulinemia
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou, et al.
Expert Review of Hematology
|
July 4, 2019
Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?
Martina Kleber, Ioannis Ntanasis-Stathopoulos, Meletios A Dimopoulos, et al.
Expert Opinion on Pharmacotherapy
|
November 15, 2017
An overview of the role of carfilzomib in the treatment of multiple myeloma
Dimitrios C Ziogas, Evangelos Terpos, Efstathios Kastritis, et al.
Expert Review of Hematology
|
May 28, 2016
A review of the venous thrombotic issues associated with multiple myeloma
Despina Fotiou, Grigoris Gerotziafas, Efstathios Kastritis, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Metabolic Disorders in Multiple Myeloma
Maria Gavriatopoulou, Stavroula A Paschou, Ioannis Ntanasis-Stathopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2023
Reply to Y. Song et al
Meletios A Dimopoulos, Stephen Opat, Steven P Treon, et al.
Hematology/Oncology Clinics of North America
|
November 13, 2007
Management of relapsed and relapsed refractory myeloma
Efstathios Kastritis, Constantine S Mitsiades, Meletios A Dimopoulos, et al.
Page
of 74
Search research articles
Search
Showing results (101-110 of 740) with videos related to
Sort By:
Page
of 74
Blood
|
April 4, 2015
Treatment options for relapsed and refractory multiple myeloma
Ajay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.
Blood Cancer Journal
|
January 14, 2018
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia
|
November 19, 2022
Managing Waldenström's macroglobulinemia with BTK inhibitors
Christian Buske, Wojciech Jurczak, Joe-Elie Salem, et al.
Therapeutic Advances in Hematology
|
February 22, 2021
Current and novel BTK inhibitors in Waldenström's macroglobulinemia
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou, et al.
Expert Review of Hematology
|
July 4, 2019
Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?
Martina Kleber, Ioannis Ntanasis-Stathopoulos, Meletios A Dimopoulos, et al.
Expert Opinion on Pharmacotherapy
|
November 15, 2017
An overview of the role of carfilzomib in the treatment of multiple myeloma
Dimitrios C Ziogas, Evangelos Terpos, Efstathios Kastritis, et al.
Expert Review of Hematology
|
May 28, 2016
A review of the venous thrombotic issues associated with multiple myeloma
Despina Fotiou, Grigoris Gerotziafas, Efstathios Kastritis, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Metabolic Disorders in Multiple Myeloma
Maria Gavriatopoulou, Stavroula A Paschou, Ioannis Ntanasis-Stathopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2023
Reply to Y. Song et al
Meletios A Dimopoulos, Stephen Opat, Steven P Treon, et al.
Hematology/Oncology Clinics of North America
|
November 13, 2007
Management of relapsed and relapsed refractory myeloma
Efstathios Kastritis, Constantine S Mitsiades, Meletios A Dimopoulos, et al.
Page
of 74